首页 | 本学科首页   官方微博 | 高级检索  
     


Association of GSTM1 Null Allele with Prostate Cancer Risk: Evidence from 36 Case-Control Studies
Authors:Bingbing Wei  Zhuoqun Xu  You Zhou  Jun Ruan  Huan Cheng  Bo Xi  Ming Zhu  Ke Jin  Deqi Zhou  Qiang Hu  Qiang Wang  Zhirong Wang  Zhiqiang Yan  Feng Xuan  Xing Huang  Jian Zhang  Hongyi Zhou
Affiliation:1. Department of Urology, Affiliated Wuxi People’s Hospital, Nanjing Medical University, Wuxi, China.; 2. Faculty of Medicine, University of Helsinki, Finland.; 3. Department of Urology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; 4. Department of Maternal and Child Health Care, School of Public Health, Shandong University, Jinan, China.; The University of Texas M. D. Anderson Cancer Center, United States of America,
Abstract:

Background

Glutathione S-transferase M1 (GSTM1) is thought to be involved in detoxifying several carcinogens and may play a vital role in tumorigenesis. Numerous studies have evaluated the association between GSTM1 null/present polymorphism and risk of prostate cancer (PCa). However, the results remain inconsistent. To derive a more precise estimation, we performed a meta-analysis.

Methodology/Principal Findings

A comprehensive search was conducted to identify all eligible case-control studies. We used odds ratios (ORs) with 95% confidence intervals (CIs) to assess the strength of the association. The overall association was significant (OR = 1.28, 95% CI: 1.11–1.48, P = 0.001). Moreover, subgroup analyses showed GSTM1 null genotype significantly associated with PCa risk among Asians (OR = 1.35, 95% CI: 1.03–1.78, P = 0.03) but not among Caucasians (OR = 1.12, 95% CI: 0.96–1.31, P = 0.16). In addition, we did not find that smoking modified the genotype effect on the risk of PCa.

Conclusions/Significance

The present meta-analysis suggested that GSTM1 null allele was a low-penetrant risk factor for PCa among Asians.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号